Literature DB >> 8117342

Treatment of microsporidial keratoconjunctivitis with topical fumagillin.

M C Diesenhouse1, L A Wilson, G F Corrent, G S Visvesvara, H E Grossniklaus, R T Bryan.   

Abstract

Encephalitozoon hellem is a newly described cause of microsporidial keratoconjunctivitis, occurring chiefly in patients with significantly diminished CD4+ T-lymphocyte levels. This disorder is symptomatically disabling and generally recalcitrant to topical antimicrobial therapy. Two homosexual men with E. hellem keratoconjunctivitis diagnosed by Gram stain, transmission electron microscopy, and specific indirect immunofluorescent assay were treated with topical fumagillin (Fumidil B). Both patients had marked symptomatic improvement with reduction of clinical findings. Symptoms and signs recurred with temporary discontinuation of the drug. Both patients, however, remained symptom-free on maintenance levels of topical fumagillin with no evidence of toxic side effects.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8117342     DOI: 10.1016/s0002-9394(14)73578-0

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  19 in total

1.  Testing intra-hemocelic injection of antimicrobials against Encephalitozoon sp. (Microsporidia) in an insect host.

Authors:  Shajahan Johny; Amanda S Nimmo; Mark A Fisher; Elizabeth S Inks; Ryan M Kirkpatrick; Philip A Miller; Adam L Johnson; Kanisha R Lites; Calli C Whitehouse; Douglas W Whitman
Journal:  Parasitol Res       Date:  2008-10-11       Impact factor: 2.289

2.  Humoral response of chicken infected with the microsporidium Encephalitozoon hellem.

Authors:  K Saková; B Sak; O Ditrich; M Kvác
Journal:  Parasitol Res       Date:  2006-01-17       Impact factor: 2.289

3.  Discovery of novel antigiardiasis drug candidates.

Authors:  Liudmila Kulakova; Andrey Galkin; Catherine Z Chen; Noel Southall; Juan J Marugan; Wei Zheng; Osnat Herzberg
Journal:  Antimicrob Agents Chemother       Date:  2014-09-29       Impact factor: 5.191

4.  Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  George K Siberry; Mark J Abzug; Sharon Nachman; Michael T Brady; Kenneth L Dominguez; Edward Handelsman; Lynne M Mofenson; Steve Nesheim
Journal:  Pediatr Infect Dis J       Date:  2013-11       Impact factor: 2.129

5.  Effects of albendazole, fumagillin, and TNP-470 on microsporidial replication in vitro.

Authors:  E S Didier
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

Review 6.  Molecular techniques for detection, species differentiation, and phylogenetic analysis of microsporidia.

Authors:  C Franzen; A Müller
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

7.  Diagnosis of disseminated microsporidian Encephalitozoon hellem infection by PCR-Southern analysis and successful treatment with albendazole and fumagillin.

Authors:  E S Didier; L B Rogers; A D Brush; S Wong; V Traina-Dorge; D Bertucci
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

8.  Flow cytometric analysis of microsporidia belonging to the genus Encephalitozoon.

Authors:  D M Moss; G P Croppo; S Wallace; G S Visvesvara
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

9.  Microsporidial keratitis: Literature review and report of 2 cases in a tertiary eye care center.

Authors:  Hind M Alkatan; Sultan Al-Zaaidi; Sreedharan Athmanathan
Journal:  Saudi J Ophthalmol       Date:  2012-02-16

10.  Susceptibility of Encephalitozoon cuniculi to several drugs in vitro.

Authors:  F F Franssen; J T Lumeij; F van Knapen
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.